Antisense oligonucleotides directed against the viral RNA polymerase gene enhance survival of mice infected with influenza A (original) (raw)
References
Detjen, B.M., St. Angelo, C. Katze, M.G. & Krug, R.M. The three influenza virus polymerase (P) proteins not associated with viral nucleocapsids in the infected cell are in the form of a complex. J. Virol.61, 16–22 (1987). CASPubMedPubMed Central Google Scholar
Nakagawa, Y. The RNA polymerase PB2 subunits is not required for replication of the influenza virus genome but is involved in capped mRNA synthesis. J. Virol. 69, 728–733 (1995).
Sanz-Ezquerro, J.J., de la Luna, S., Ortin, J. & Nieto, A. Individual expression of influenza virus PA protein induces degradation of coexpressed proteins. J. Virol.69, 2420–2426 (1995). CASPubMedPubMed Central Google Scholar
Rothenberg, M. et al. Oligodeoxynucleotides as antisense inhibitor of gene expression: therapeutic implications. J. Natl. Cancer. Inst.81, 1538–1544 (1989). Google Scholar
Zamecnik, P.C. & Stephenson, M.L. Inhibition of Rous sarcoma virus replication and transformation by a specific oligodeoxynucleotide. Proc. Natl. Acad. Sci. USA75, 280–284 (1978). ArticleCAS Google Scholar
Zamecnik, P.C., Goodchild, J., Taguchi, Y. & Sarin, P.S. Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic immunodeficiency oligonucleotides complementary to viral RNA. Proc. Natl. Acad. Sci. USA83, 4143–4146 (1986). ArticleCAS Google Scholar
Miller, P.S. et al. Control ribonucleic acid function by oligonucleotide methylphosphonates. Biochimie67, 769–776 (1985). ArticleCAS Google Scholar
Smith, C.C., Aurelian, L., Reddy, M.P., Miller, P.S. & Ts'o, P.O.P. Antiviral effect of an oligo (nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5. Proc. Natl. Acad. Sci. USA83, 2787–2791 (1986). ArticleCAS Google Scholar
Matsukura, M. et al. Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA84, 7706–7710 (1987). ArticleCAS Google Scholar
Zerial, A., Thuong, N.T. & Hélène, C. Selective inhibition of the cytopathic effect of type A influenza virus by oligonucleotides covalently linked to an intercalating agent. Nucleic Acids Res.15, 9909–9919 (1987). ArticleCAS Google Scholar
Leiter, J.M.E., Agrawal, S., Palese, P. & Zamecnik, P.C. Inhibition of influenza virus replication by phosphorothioate oligonucleotides. Proc. Natl. Acad. Sci. USA87, 3430–3434 (1990). ArticleCAS Google Scholar
Kim, S-G. et al. Anti-HIV activities and physicochemical properties of phosphorothioate analogues complementary to HIV sequences. Bioorg. Med. Chem. Lett.3, 1223–1228 (1993). ArticleCAS Google Scholar
Kim, S-G. et al. Antiviral effect of phosphorothioate oligodeoxyribonucleotides complementary to human immunodeficiency virus. Bioorg. Med. Chem. Lett.3, 49–54 (1995). ArticleCAS Google Scholar
Whitesell, L., Rosolen, A. & Neckers, L.M. In vitro modulation of N-myc expression by continuous perfusion with an antisense oligonucleotide. Antisense Res. Dev.1, 343–350 (1991). ArticleCAS Google Scholar
Simons, M., Edelman, E.R., DeKeyser, J-L., Langer, R. & Rosenberg, R.D. Antisense c- myb oligonucleotides inhibit arterial smooth muscle cell accumulation in vivo. Nature359, 67–70 (1992). ArticleCAS Google Scholar
Skorski, T. et al. Suppression of Philadelphia leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide. Proc. Natl. Acad. Sci. USA91, 4504–4508 (1994). ArticleCAS Google Scholar
Hélène, C. & Toulmé, J.J. Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim. Biophys. Acta149, 99–125 (1990). Article Google Scholar
Erickson, R.P. & Yzant, J.G. Gene regulation, biology of antisense RNA and DNA (Raven, London; 1992). Google Scholar
Miller, P.S., Mc Parland, K.B., Yayaraman, N. & Ts'o, P.O.P. Biochemical and biological effects of nonionic nucleic acid methylphosphonates. Biochemistry20, 1874–1880 (1981). ArticleCAS Google Scholar
Stec, W., Zon, G., Egan, W. & Stec, B. Automated solid-phase synthesis, separation, and stereochemistry of phosphorothioate analogs of oligodeoxyribonucleotides. J. Am. Chem. Soc.106, 6077–6079 (1984). ArticleCAS Google Scholar
Agrawal, S. et al. Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA85, 7079–7083 (1988). ArticleCAS Google Scholar
Wickstroms, E.L. et al. Human promyelocitic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide target against c-myc mRNA. Proc. Natl. Acad. Sci. USA85, 1028–1032 (1988). Article Google Scholar
Stein, C.A. et al. Phosphorothioate oligodeoxycytidine interferes with binding of HIV-1 gp120 to CD4. J. Acq. Imm. Defi. Synd.4, 686–6939 (1991). CAS Google Scholar
Yakubov, L.A. et al. Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? Proc. Natl. Acad. Sci. USA86, 6454–6458 (1989). ArticleCAS Google Scholar
Leonetti, J.P., Machy, P., Degols, G., Lebleu, B. & Leserman, L. Antibody targeted liposomes containing oligodeoxyribonucleotides complementary to viral RNA selectively inhibited viral replication. Proc. Natl. Acad. Sci. USA87, 2448–2451 (1989). Article Google Scholar
Milhaud, P.G., Machy, P., Colote, S., Lebleu, B. & Leserman, L. Free and liposome-encapsulated double-stranded RNAs as inducers of interferon, interleukin-6, and cellular toxicity. J. Interferon Res.11, 261–265 (1991). ArticleCAS Google Scholar
Thierry, A.R. & Dritschilo, A. Intracellular availability unmodified phosphorothioate and liposomally encapsulated oligodeoxyribonucleotides for antisense activity. Nucleic Acids Res.21, 5691–5698 (1992). Article Google Scholar
Hatta, T. et al. Inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by unmodified, phosphorothioated, and liposomally encapsulated oligonucleotides. Biochem. Biophys. Res. Commun.223, 341–346 (1996). ArticleCAS Google Scholar
Hatta, T., Takai, K., Nakada, S., Yokota, T. & Takaku, H. Specific inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by liposomally endocapsulated antisense phosphorothioate oligonucleotides: penetration and localization of oligonucleotides in clone 76 cells. Biochem. Biophys. Res. Commun.232, 545–549 (1997). ArticleCAS Google Scholar
Bennett, C.F., Chaing, M-Y., Chang, H., Schoemaker, J.E. & Mirabelli, C.K. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharmacol.41, 1023–1033 (1992). CASPubMed Google Scholar
Stewart, M.J. Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice. Hum. Gene Ther.3, 267–275 (1992). ArticleCAS Google Scholar
Keogh, M.-C. High efficiency reporter gene transfection of vascular tissue in vitro and in vivo using a cationic lipid-DNA complex. Gene Ther.4, 162–171 (1997). ArticleCAS Google Scholar
Lewis, J.G. A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA. Proc. Natl. Acad. Sci. USA93, 3176–3181 (1996). ArticleCAS Google Scholar
Abe, T. et al. Specific inhibition of influenza virus RNA polymerase and nucleoprotein gene expression by liposomally encapsulated antisense phosphorothioate oligonucleotides in MDCK cells. Antivir. Chem. Chemother.9, 253–262 (1998). ArticleCAS Google Scholar
Yamashita, M., Krystal, M. & Palese, P. Comparison of the three large polymerase proteins of influenza A, B, and C viruses. Virology171, 458–466 (1989). ArticleCAS Google Scholar
Jambrina, E., Barcena, J., Uez, O. & Portela, A. The three subunits of the polymerase and the nucleoprotein of influenza B virus are the minimum set of viral proteins required for expression of a model RNA template. Virology235, 209–217 (1997). ArticleCAS Google Scholar
Agatsuma, T. et al. Protection of hu-PBL-SCID/beige mice from HIV-1 infection by a 6-mer modified oligonucleotide, R-95288. Antiviral Res.34, 121–130 (1997). ArticleCAS Google Scholar
Stein, C.A. Does antisense exist?: it may, but only under very special circumstances. Nat. Med.11, 1119–1121 (1995). Article Google Scholar
Stein, C.A. & Cheng, Y.-C. Antisense oligonucleotides as therapeutic agents—is the bullet really magical? Science261,1004–1012 (1993). ArticleCAS Google Scholar
Stein, C.A. & Krieg, A.M. Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides. Antisense Res. Dev.4, 67–69 (1994). ArticleCAS Google Scholar
Wagner, R.W. Gene inhibition using antisense oligodeoxynucleotides. Nature372, 333–335 (1994). ArticleCAS Google Scholar
Davis, H.L. et al. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol.160, 870–876 (1998). CASPubMed Google Scholar
Brazolot Millan, C.L., Weeratna, R., Krieg, A.M., Siegrist, C-A. & Davis, H.L. CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice. Proc. Natl. Acad. Sci. USA95, 15553–15558 (1998). ArticleCAS Google Scholar
Liu, Y. et al. Cationic liposome-mediated intravenous gene delivery. J. Biol. Chem.270, 24864–24870 (1995). ArticleCAS Google Scholar
Zhu, N., Liggitt, D., Liu, Y. & Debs, R. Systemic gene expression after intravenous DNA delivery into adult mice. Science261, 209–211 (1993). ArticleCAS Google Scholar